Disclosures for "Acquired Urea Cycle Disorder From Zinc Deficiency Causing Hyperammonemic Encephalopathy and Refractory Status Epilepticus "
-
Dr. Miller has nothing to disclose.
-
Dr. Suh has nothing to disclose.
-
Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
-
Dr. Pastula has nothing to disclose.
-
The institution of Dr. Hountras has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for United Therapeutics. The institution of Dr. Hountras has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Dr. Hountras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. The institution of Dr. Hountras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamerbio. The institution of Dr. Hountras has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Inari. The institution of Dr. Hountras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imperative Care. The institution of Dr. Hountras has received research support from Inari. The institution of Dr. Hountras has received research support from Department of Defense. The institution of Dr. Hountras has received research support from HRSA. The institution of Dr. Hountras has received research support from NIH.